BOS 0.00% 1.5¢ biosignal limited

whats the outlook, page-14

  1. 420 Posts.
    I think Hawken was speaking out aloud what we were all thinking, that the product is worth a damn lot of money. Looks like he just couldn't raise the funds necessary to start the spin off companies. Probably not the best climate for it, particularly in the US.

    If we don't get some big cash coming in soon, maybe a total buyout by a major global company might be on the cards. This technology needs a lot of cash thrown at it. I'm certain once it gets on the market it will justify the development costs, even very high ones.

    Company currently valued by the market at $5 million. :-(
 
watchlist Created with Sketch. Add BOS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.